ACLX
Arcellx Inc
NASDAQ: ACLX · HEALTHCARE · BIOTECHNOLOGY
$115.07
+0.00% today
Updated 2026-04-28
Market cap
$6.73B
P/E ratio
—
P/S ratio
302.04x
EPS (TTM)
$-4.07
Dividend yield
—
52W range
$48 – $115
Volume
2.8M
Arcellx Inc (ACLX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-3,850.00%
ROE
-53.40%
ROA
-24.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | — | $-8.31M | — | — | — |
| 2019 | $0.00 | $-17.97M | — | — | — |
| 2020 | $0.00 | $-32.09M | — | — | — |
| 2021 | $0.00 | $-63.93M | — | — | — |
| 2022 | $17.91M | $-188.68M | -12.42% | -1,067.77% | -1,053.37% |
| 2023 | $110.32M | $-70.69M | 100.00% | -81.47% | -64.08% |
| 2024 | $107.94M | $-107.35M | 95.19% | -127.46% | -99.46% |
| 2025 | $22.29M | $-228.93M | 70.03% | -1,135.61% | -1,027.25% |